Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Cortes

Showing results (361-370 of 584) with videos related to

Pageof 59
Sort By:
Cancer|April 4, 2006
Thalidomide therapy for myelofibrosis with myeloid metaplasiaDeborah A Thomas, Francis J Giles, Maher Albitar, et al.
Veterinary Parasitology|July 11, 2006
Isolation of Besnoitia besnoiti from infected cattle in PortugalH C E Cortes, Y Reis, H Waap, et al.
Blood Cancer Journal|May 7, 2016
Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapyZ Chen, W Wang, J E Cortes, et al.
Cardio-Oncology (London, England)|November 26, 2025
CPX-351 vs. conventional chemotherapy cardiotoxicity in high-risk AML: a post hoc phase III trial analysisJoshua D Mitchell, Michael Pfeiffer, John Boehmer, et al.
Cancer|August 11, 2016
A propensity score matching analysis of dasatinib and nilotinib as a frontline therapy for patients with chronic myeloid leukemia in chronic phaseKoichi Takahashi, Hagop M Kantarjian, Yulong Yang, et al.
Cancer|October 20, 2015
Conditional survival in patients with chronic myeloid leukemia in chronic phase in the era of tyrosine kinase inhibitorsKoji Sasaki, Hagop M Kantarjian, Preetesh Jain, et al.
International Journal of Hematology|March 2, 2022
Safety profile of bosutinib in Japanese versus non-Japanese patients with chronic myeloid leukemia: a pooled analysisNaoto Takahashi, Jorge E Cortes, Emiko Sakaida, et al.
Blood Advances|July 16, 2025
Olutasidenib alone or combined with azacitidine in patients with mutant IDH1 myelodysplastic syndromeJorge E Cortes, Jay Yang, Gail J Roboz, et al.
The Journal of Molecular Diagnostics : JMD|May 31, 2012
Detection of high-frequency and novel DNMT3A mutations in acute myeloid leukemia by high-resolution melting curve analysisRajesh R Singh, Ashish Bains, Keyur P Patel, et al.
Blood|June 20, 2013
Measuring the symptom burden associated with the treatment of chronic myeloid leukemiaLoretta A Williams, Araceli G Garcia Gonzalez, Patricia Ault, et al.
Pageof 59

Showing results (361-370 of 584) with videos related to

Sort By:
Pageof 59
Cancer|April 4, 2006
Thalidomide therapy for myelofibrosis with myeloid metaplasiaDeborah A Thomas, Francis J Giles, Maher Albitar, et al.
Veterinary Parasitology|July 11, 2006
Isolation of Besnoitia besnoiti from infected cattle in PortugalH C E Cortes, Y Reis, H Waap, et al.
Blood Cancer Journal|May 7, 2016
Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapyZ Chen, W Wang, J E Cortes, et al.
Cardio-Oncology (London, England)|November 26, 2025
CPX-351 vs. conventional chemotherapy cardiotoxicity in high-risk AML: a post hoc phase III trial analysisJoshua D Mitchell, Michael Pfeiffer, John Boehmer, et al.
Cancer|August 11, 2016
A propensity score matching analysis of dasatinib and nilotinib as a frontline therapy for patients with chronic myeloid leukemia in chronic phaseKoichi Takahashi, Hagop M Kantarjian, Yulong Yang, et al.
Cancer|October 20, 2015
Conditional survival in patients with chronic myeloid leukemia in chronic phase in the era of tyrosine kinase inhibitorsKoji Sasaki, Hagop M Kantarjian, Preetesh Jain, et al.
International Journal of Hematology|March 2, 2022
Safety profile of bosutinib in Japanese versus non-Japanese patients with chronic myeloid leukemia: a pooled analysisNaoto Takahashi, Jorge E Cortes, Emiko Sakaida, et al.
Blood Advances|July 16, 2025
Olutasidenib alone or combined with azacitidine in patients with mutant IDH1 myelodysplastic syndromeJorge E Cortes, Jay Yang, Gail J Roboz, et al.
The Journal of Molecular Diagnostics : JMD|May 31, 2012
Detection of high-frequency and novel DNMT3A mutations in acute myeloid leukemia by high-resolution melting curve analysisRajesh R Singh, Ashish Bains, Keyur P Patel, et al.
Blood|June 20, 2013
Measuring the symptom burden associated with the treatment of chronic myeloid leukemiaLoretta A Williams, Araceli G Garcia Gonzalez, Patricia Ault, et al.
Pageof 59